SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
81
|
HIV-1 Infection and Type-1 Interferon
Michael H. Malim
King's College London, London, United Kingdom
PEPFAR/Global Fund at 10 years: Past, Present, and Future
Stefano M. Bertozzi
University of California Berkeley School of Public Health, Berkeley, CA, United States
Age-Disparate Relationships and HIV Incidence Amongst Rural South Africa Women
Guy Harling
Global Health and Population, Harvard School of Public Health, Boston, MA, United States
Introduction of HIV into Stable Heterosexual Couples in Rakai, Uganda Before and After ART
Mary K. Grabowski
Epidemiology, The Johns Hopkins University, Baltimore, MD, United States
One Year Outcomes Following Community-Based HIV Self-Testing: A Prospective Study in Malawi
Augustine T. Choko
Malawi Liverpool Wellcome Trust Clinical Research Programme, Blantyre, Malawi
Community HIV Testing and Linkage To Care Reduces Population Viral Load in South Africa and Uganda
Ruanne V. Barnabas
Global Health and Medicine, University of Washington, Seattle, WA, United States and Fred Hutchinson Cancer Research Center, Seattle, WA, United States
Enhanced HIV Surveillance To Evaluate the National Response To HIV/AIDS in Kenya
William Maina
National AIDS and STI Control Programme, Ministry of Health, Nairobi, Kenya
Unequal Benefits From ART: A Growing Male Disadvantage in Life Expectancy in Rural South Africa
Till Barnighausen
Global Health and Population, Harvard School of Public Health, Boston, MA, United States and Africa Centre for Health and Population Studies, Mtubatuba, South Africa
A New Paradigm for Evaluating the HIV Care Cascade
Margaret L. McNairy
ICAP Columbia University, New York, NY, United States
Moderate HIV Incidence and High ART Coverage in Rural Kwazulu-Natal: First Population-Based Survey
Helena Huerga
Epicentre, Paris, France
Increased Arterial Inflammation Relates to High-Risk Coronary Plaque Morphology in HIV+ Patients
Markella V. Zanni
Program in Nutritional Metabolism, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States
Arterial Inflammation in HIV as Measured by FDG-PET/CT Is Associated With Splenic Activity
Priscilla Y. Hsue
Cardiology, University of California San Francisco, San Francisco, CA, United States
Replicative Senescence of Circulating Osteogenic Cells and Low BMD in Perinatally Infected Men
Michael T. Yin
Columbia University Medical Center, New York, NY, United States
High-Dose Vitamin D and Calcium Attenuates Bone Loss With ART Initiation: Results From ACTG A5280
Edgar T. Overton
University of Alabama School of Medicine, Birmingham, AL, United States
Rosuvastatin Improves Hip Bone Mineral Density But Worsens Insulin Resistance
Grace A. McComsey
Case Western Reserve University, Cleveland, OH, United States
Effects of Tesamorelin On Hepatic Fat in HIV Patients: A Randomized, Placebo-Controlled Trial
Steven Grinspoon
Massachusetts General Hospital, Boston, MA, United States
Cryo-EM Structures of the HIV-1 Env Trimer Reveal the Full Extent of Neutralizing Antibody Epitopes
Andrew B. Ward
Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, United States
Immunogenicity of Cleaved, Soluble BG505 SOSIP.664 Native-Like Trimers in Rabbits
John P. Moore
Microbiology/Immunology, Weill Medical College, New York, NY, United States
Identification of a New Neutralization Target at the N262/N448 Glycosylation Sites On HIV-1 gp120
Xueling Wu
Aaron Diamond AIDS Research Center, New York, NY, United States
CD169 Mediates HIV-1 Evasion From Detection by α-gp120 Neutralizing Antibodies in Dendritic Cells
Hisashi Akiyama
Microbiology, Boston University School of Medicine, Boston, MA, United States
Tetherin Antagonism by Vpu Protects HIV-Infected Cells From ADCC
Juan F. Arias
Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States
HIV Nef and Vpu Protect HIV-infected CD4+ T Cells From ADCC Through Downmodulation of CD4 and BST2
Tram N. Q. Pham
Institut de Recherches Cliniques de Montréal, Montreal, QC, Canada
Identification of HIV-infected CD4+ T Cells Using HIV RNA and Broadly Neutralizing Antibodies
Joseph P. Casazza
Immunology Laboratory, NIAID, Bethesda, MD, United States
Type I Interferon Signaling Is Critical for Early Control of Immune System Damage
Netanya G. Sandler
Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, TX, United States
miR-422a: A Solitary MicroRNA Biomarker of Interferon-α Anti-HIV-1 Activity In Vivo
Mohamed Abdel-Mohsen
Medicine, University of California, San Francisco, San Francisco, CA, United States and Blood Systems Research Institute, San Francisco, CA, United States
Moderator
Mary Kearney
National Cancer Institute, Frederick, MD, United States
Early Treatment in Acute SIV Infection Limits the Size and Distribution of the Viral Reservoir
Afam A. Okoye
Vaccine & Gene Therapy Institute and the Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, United States
CD4 T-Cell Subset Composition of HIV Reservoirs in Gut, Lymphnode, and Blood During HAART
Joseph K. Wong
University of California San Francisco, San Francisco, CA, United States and San Francisco Veterans Affairs Medical Center, San Francisco, CA, United States
Proliferation of Cells With HIV Integrated Into Regulatory Genes Is a Mechanism of Persistence
Thor A. Wagner
University of Washington, Seattle, WA, United States and Seattle Children's Hospital, Seattle, WA, United States
Novel Ex Vivo Approaches Distinguish Effective and Ineffective Drugs for Reversing Latency In Vivo
Gregory M. Laird
The Johns Hopkins University School of Medicine, Baltimore, MD, United States
Effect of Vorinostat On Host Gene Expression in HIV Infected Patients On Antiretroviral Therapy
Khader Ghneim
VGTI-FL, Port Saint Lucie, FL, United States
Cyclophosphamide Enhances SB-728-T Engraftment To Levels Associated With HIV-RNA Control
Gary Blick
Circle Care Center, Norwalk, CT, United States
Stimulation of Subdominant CTL Response Is Required for the Elimination of HIV-1 Latent Reservoir
Kai Deng
The Johns Hopkins University, Baltimore, MD, United States
Dendritic Cell-Based HIV Therapeutic Vaccine Increases Residual Viremia in Individuals On ART
Bernard J. Macatangay
Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States
HIV-1 Rebound Following Allogeneic Stem Cell Transplantation and Treatment Interruption
Timothy J. Henrich
Brigham and Women's Hospital, Harvard Medical School, Cambridge, MA, United States
Discussion Leader
Scott L. Letendre
University of California San Diego, San Diego, CA, United States
CNS Outcomes of cART vs. cART plus Maraviroc and Raltegravir Intensification During Acute HIV
James L. K. Fletcher
SEARCH, The Thai Red Cross AIDS Research Center, Bangkok, Thailand
HIV-1 RNA Detection in CSF in ART-Treated Subjects With Incomplete Viral Suppression in Plasma
Sam Nightingale
Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
CSF Viral Escape in Patients Without Neurological Disorders: Prevalence and Associated Factors
Carmela Pinnetti
National Institute for Infectious Disease, Rome, Italy
Cerebrospinal Fluid Viral Blips and Persistent Escape in HIV-Infected Patients On ART
Arvid Eden
University of Gothenburg, Gothenburg, Sweden
Mitochondrial DNA Is Associated With Inflammation and Neurocognitive Deficits in HIV Infection
Josué Pérez-Santiago
Medicine, University of California San Diego, La Jolla, CA, United States
Early Monocyte Inflammation Among Treatment-Naïve Acute HIV-Infected Thai Subjects
Lishomwa C. Ndhlovu
Hawaii Center for AIDS, University of Hawaii, Honolulu, HI, United States
Discussion Leader
Christine M. Rousseau
Bill and Melinda Gates Foundation, Seattle, WA, United States
Performance of the Limiting-Antigen Avidity EIA for Use With Dried Blood Spot Specimens
Erin K. Rottinghaus
Centers for Disease Control and Prevention, Atlanta, GA, United States
Incorrect Identification of Recent HIV Infection Using a LAg-Avidity Assay in Adults in the US
Andrew F. Longosz
Laboratory of Immunoregulation, Division of Intramural Research, National Insitutes of Health, Baltimore, MD, United States
The Impact of HIV Subtype On Specificity of Cross-Sectional HIV Incidence Assays in Rakai, Uganda
Andrew F. Longosz
NIAID, National Insitutes of Health, Baltimore, MD, United States
Independent Evaluation of Predicate Incidence Assays for HIV Surveillance
Alex Welte
The South African DST/NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa
Discussion Leader
Thomas S. Uldrick
National Cancer Institute, Bethesda, MD, United States
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
81
|
